Rosario Davidson
Medical · Elizabeth, NJNPI 1972778785
Payments from drug & device makers
Across 301 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$702
- Lilly USA, LLC$636
- AbbVie$434
- Novo Nordisk$345
- Dexcom, Inc.$333
- Sanofi-aventis U.S. LLC$277
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,704100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 40 | $702 |
| Lilly USA, LLC | 45 | $636 |
| AbbVie | 31 | $434 |
| Novo Nordisk | 24 | $345 |
| Dexcom, Inc. | 19 | $333 |
| Sanofi-aventis U.S. LLC | 19 | $277 |
| Abbott | 11 | $195 |
| Boehringer Ingelheim | 11 | $168 |
| Amgen | 10 | $159 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $138 |
| Merck | 9 | $131 |
| Scilex Pharmaceuticals Inc. | 8 | $125 |
| Pfizer | 8 | $122 |
| Novartis | 8 | $114 |
| Corcept Therapeutics | 6 | $102 |
| Daiichi Sankyo Inc. | 6 | $90 |
| Johnson & Johnson(2 entities) | 5 | $83 |
| GSK | 4 | $72 |
| Exact Sciences | 2 | $60 |
| Phathom Pharmaceuticals, Inc. | 4 | $59 |
| Bausch Health US, LLC | 3 | $54 |
| Astellas Pharma US Inc | 3 | $53 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $49 |
| Neurocrine Biosciences, Inc. | 3 | $47 |
| Lundbeck LLC | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Nevro Corp. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Gilead | 1 | $16 |
| Optinose US, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$4,704 in reported general payments places this provider in the 85th percentile of 573 medical providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 143 | $135,353 |
| OzempicSemaglutide | 118 | $132,349 |
| FarxigaDapagliflozin Propanediol | 111 | $87,334 |
| EliquisApixaban | 103 | $76,263 |
| JardianceEmpagliflozin | 61 | $71,493 |
| TrulicityDulaglutide | 38 | $54,146 |
| TradjentaLinagliptin | 54 | $41,792 |
| LinzessLinaclotide | 40 | $37,627 |
| XareltoRivaroxaban | 39 | $34,070 |
| EntrestoSacubitril/Valsartan | 17 | $23,709 |
| JanumetSitagliptin Phos/Metformin Hcl | 20 | $23,332 |
| Breo ElliptaFluticasone/Vilanterol | 28 | $16,627 |
| VascepaIcosapent Ethyl | 19 | $14,682 |
| Spiriva HandihalerTiotropium Bromide | 17 | $14,094 |
| MyrbetriqMirabegron | 28 | $13,396 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet, Steglatro, Belsomra | $131 | $172,526192 claims |
| Novo NordiskOzempic | $345 | $132,349118 claims |
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat, Stiolto Respimat | $168 | $127,997144 claims |
| AstraZenecaFarxiga, Symbicort, Nexium | $702 | $96,577136 claims |
| PfizerEliquis | $122 | $76,263103 claims |
| Lilly USA, LLCTrulicity | $636 | $54,14638 claims |
| AbbVieLinzess, Creon | $434 | $49,60256 claims |
| Johnson & JohnsonXarelto | $83 | $34,07039 claims |
| GSKBreo Ellipta, Arnuity Ellipta, Anoro Ellipta | $72 | $28,54963 claims |
| NovartisEntresto | $114 | $23,70917 claims |
| Astellas Pharma US IncMyrbetriq | $53 | $13,39628 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $277 | $10,46012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 573 medical providers in New Jersey.
Other medical in Elizabeth
- Alison PietrasBrick$1.2M
- Shannon WelnerVerona$176K
- Christinna DelgenioColts Neck$114K
- Anita FoxVerona$17K
- Therese CasasKinnelon$16K
- Joseph CollettiLinwood$16K
- Melissa MiaoKearny$14K
- Gabriela Plesek-AndiaVerona$13K
- Stephanie PhillipsMarlton$12K
- Sean AdairCape May Court House$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.